Clinical Trials Browser

Phase 3 × Terminated × daratumumab × Clear all

NCT05675319 2026-01-05

AlloRelapseMM

Phase 3 Terminated

Multiple Myeloma

NCT04649060 2023-06-08

LIGHTHOUSE

Phase 3 Terminated

54 enrolled 21 charts

Multiple Myeloma